Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Ovarian Neoplasms

  Free Subscription


15.08.2022

2 Anticancer Drugs
2 Br J Cancer
1 Clin Med Insights Oncol
1 Gynecol Oncol
1 Histopathology
1 Int J Cancer
1 Int J Oncol
1 J Clin Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Anticancer Drugs

  1. SHAN Y, Zhang B, Chen L, Zhang H, et al
    Herpesvirus entry mediator regulates the transduction of Tregs via STAT5/Foxp3 signaling pathway in ovarian cancer cells.
    Anticancer Drugs. 2022 Aug 9. pii: 00001813-990000000-00021.
    PubMed         Abstract available

  2. ZHANG X, Hong S, Yang J, Liu J, et al
    Purvalanol A induces apoptosis and reverses cisplatin resistance in ovarian cancer.
    Anticancer Drugs. 2022 Aug 9. pii: 00001813-990000000-00018.
    PubMed         Abstract available


    Br J Cancer

  3. GAHLAWAT AW, Witte T, Haarhuis L, Schott S, et al
    A novel circulating miRNA panel for non-invasive ovarian cancer diagnosis and prognosis.
    Br J Cancer. 2022 Aug 5. pii: 10.1038/s41416-022-01925.
    PubMed         Abstract available

  4. KOIZUME S, Takahashi T, Nakamura Y, Yoshihara M, et al
    Lipophagy-ICAM-1 pathway associated with fatty acid and oxygen deficiencies is involved in poor prognoses of ovarian clear cell carcinoma.
    Br J Cancer. 2022 Apr 21. pii: 10.1038/s41416-022-01808.
    PubMed         Abstract available


    Clin Med Insights Oncol

  5. BARVE M, Aaron P, Manning L, Bognar E, et al
    Pilot Study of Combination Gemogenovatucel-T (Vigil) and Durvalumab in Women With Relapsed BRCA-wt Triple-Negative Breast or Ovarian Cancer.
    Clin Med Insights Oncol. 2022;16:11795549221110501.
    PubMed         Abstract available


    Gynecol Oncol

  6. KUMAR A, Wang C, Sheedy SP, McCauley BM, et al
    Into the future: A pilot study combining imaging with molecular profiling to predict resectability in ovarian cancer.
    Gynecol Oncol. 2022 Aug 2. pii: S0090-8258(22)00492.
    PubMed         Abstract available


    Histopathology

  7. BENNETT JA, Oliva E
    The complex and often confusing history, histology and histogenesis of mesonephric, STK11 adnexal tumour and mesonephric-like neoplasms of the upper female genital tract (including broad ligament).
    Histopathology. 2022;81:280-296.
    PubMed         Abstract available


    Int J Cancer

  8. SA JK, Kim J, Kang S, Kim SW, et al
    Somatic genomic landscape of East Asian epithelial ovarian carcinoma and its clinical implications from prospective clinical sequencing; A Korean Gynecologic Oncology Group study (KGOG 3047).
    Int J Cancer. 2022 Jun 6. doi: 10.1002/ijc.34150.
    PubMed         Abstract available


    Int J Oncol

  9. WANG Y, Han A, Chen E, Singh RK, et al
    [Corrigendum] The cranberry flavonoids PAC DP9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cells.
    Int J Oncol. 2022;61.
    PubMed         Abstract available


    J Clin Oncol

  10. FU S, Corr BR, Culm-Merdek K, Mockbee C, et al
    Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer.
    J Clin Oncol. 2022;40:2568-2577.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: